Siljander Breana R, Chandi Sonia K, Cororaton Agnes D, Debbi Eytan M, McLawhorn Alexander S, Sculco Peter K, Chalmers Brian P
Hospital for Special Surgery, New York, New York.
J Arthroplasty. 2024 Oct;39(10):2490-2495. doi: 10.1016/j.arth.2024.05.029. Epub 2024 May 15.
The impact of a preoperative self-reported nickel allergy in patients undergoing primary total knee arthroplasty (TKA) remains unclear. The aim of this study was to compare the revision rates and outcomes of patients who have a self-reported nickel allergy undergoing primary TKA to patients who do not have a self-reported nickel allergy.
Over 5 years, a total of 284 TKAs in patients who have and 17,735 in patients who do not have a self-reported nickel allergy were performed. Revision rates and differences in preoperative and postoperative patient-reported outcome measures, including Knee Osteoarthritis Outcome Score Joint Replacement (KOOS JR), Visual Analog Scale, Lower Extremity Activity Scale, and the Patient-Reported Outcomes Measurement Information System Mental and Physical Scores, were compared.
Survivorship free of all-cause revision at 1 year was similar for patients who have and do not have a self-reported nickel allergy (99.5% [95% CI (confidence interval): 98.6 to 100.0] versus 99.3% [95% CI: 99.1 to 99.4]), P = .49). Patients who have a self-reported nickel allergy undergoing primary TKA had no difference in KOOS JR, Visual Analog Scale, or Lower Extremity Activity Scale scores at 6 weeks and 1 year and slightly worse Patient-Reported Outcomes Measurement Information System mental and physical scores at 6 weeks compared to patients who did not have an allergy. Matched analysis revealed no difference in 6-week or 1-year KOOS, JR scores between patients who did and did not have a self-reported nickel allergy when stratified by implant class (nickel-free versus standard cobalt-chromium) (P = .113 and P = .415, respectively).
Patients who have a self-reported nickel allergy can be advised that, on average, their clinical outcome scores will improve similarly to patients who do not have a self-reported nickel allergy, and revision rates will be similar.
术前自我报告的镍过敏对初次全膝关节置换术(TKA)患者的影响尚不清楚。本研究的目的是比较自我报告有镍过敏的初次TKA患者与无自我报告镍过敏的患者的翻修率及手术效果。
在5年多的时间里,对自我报告有镍过敏的患者进行了284例TKA手术,对无自我报告镍过敏的患者进行了17735例TKA手术。比较了翻修率以及术前和术后患者报告的结局指标差异,包括膝关节骨关节炎结局评分关节置换版(KOOS JR)、视觉模拟量表、下肢活动量表以及患者报告结局测量信息系统的心理和生理评分。
自我报告有镍过敏和无镍过敏的患者在1年时无全因翻修的生存率相似(99.5%[95%置信区间(CI):98.6至100.0]对99.3%[95%CI:99.1至99.4]),P = 0.49)。自我报告有镍过敏的初次TKA患者在6周和1年时的KOOS JR、视觉模拟量表或下肢活动量表评分与无过敏的患者无差异,且在6周时患者报告结局测量信息系统的心理和生理评分略差。匹配分析显示,按植入物类型(无镍与标准钴铬)分层时,自我报告有镍过敏和无镍过敏的患者在6周或1年时的KOOS JR评分无差异(分别为P = 0.113和P = 0.415)。
对于自我报告有镍过敏的患者,可以告知他们,平均而言,其临床结局评分改善情况与无自我报告镍过敏的患者相似,且翻修率也相似。